Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash
14/11/2023 13:11
Nov 14 (Reuters) - Talis Biomedical Corp TLIS.O :
* TALIS BIOMEDICAL ANNOUNCES EXPLORATION OF STRATEGIC
ALTERNATIVES
AND COST REDUCTION PLAN TO PRESERVE CASH
* TALIS BIOMEDICAL CORP - REDUCING ITS WORKFORCE BY
APPROXIMATELY
90 PERCENT
* TALIS BIOMEDICAL CORP - CONSOLIDATING OPERATIONS TO A
SINGLE
SITE IN CHICAGO
* TALIS BIOMEDICAL CORP - WILL BE IMPLEMENTING ADDITIONAL
COST-SAVING MEASURES TO LOWER CASH BURN
* TALIS BIOMEDICAL CORP - DUE TO ITS EXPLORATION OF
STRATEGIC
ALTERNATIVES, TALIS BIOMEDICAL WILL NOT HOST A CONFERENCE CALL
TO DISCUSS Q3 RESULTS
Source text for Eikon: ID:nGNX27z29k
Further company coverage: TLIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talis Biomedical
See all newsBrief: Talis Biomedical Says Nasdaq Believes Co Is 'Public Shell' And Continued Listing Of Its Common Stock Is No Longer Warranted
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash